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Introduction
Children admitted to Pediatric Intensive Care 
Unit (PICU) have life threatening illnesses. They either 
already have infection when admitted or are at high-risk 
of acquiring infections because of different procedures, 
use of invasive devices, and extended length of stay.[1] 
These are the known risk factors for acquiring health 
care associated infections (HAIs) which can be quite 
difficult to treat but are preventable to an extent.[2] HAIs 
have been reported to be in 16–23% of patients admitted 
in PICUs.[3,4] Antibiotics are the most commonly used 
medicines in the Intensive Care Units (ICUs).[5] The 
critical nature of the illness of patients admitted to PICU 
and the high-risk of developing HAIs often leads to 
the prescription of multiple and prolonged antibiotics. 
The use of antibiotics may be helpful in preventing 
HAIs, but their unnecessary and irrational use has a few 
serious disadvantages. Prolonged and inappropriate 
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Background: Pediatric Intensive Care Unit (PICU) patients are often prescribed 
antibiotics with a low threshold in comparison to patients elsewhere. Irrational antibiotics 
use can lead to rapid emergence of drug resistance, so surveillance of their use is important. 
Objectives: To evaluate the use of antibiotics in relation to bacteriological findings in 
PICU of a Tertiary Hospital. Methods: Retrospective review of medical records of all 
children (age 1 month–16 years) admitted in our closed multidisciplinary‑cardiothoracic 
PICU from January to June 2013 was performed, after approval from Ethical Review 
Committee. For each antibiotic, indication (prophylactic, empiric, therapeutic) and 
duration of use were recorded. All diagnoses of infections were recorded according to 
diagnostic criteria of IPSCC 2005. Results are presented as frequency and percentages 
and median with inter quartile range using SPSS version 19. Results: All of the total 
240 patients admitted in PICU during the study period received antibiotics: 43% (n = 104) 
prophylactically, 42% (n = 102) empirically, and 15% (n = 15) therapeutically. Median number 
of antibiotic use per patient in PICU was 3, with range of 1–7.  25% received 1 antibiotic, 
23% received 2 antibiotics, 29% received 3 antibiotics, and rest received ≥4 antibiotics. Most 
commonly used antibiotics were cefazolin, meropenem, vancomycin and ceftriaxone, and 
most frequently used combination was meropenem and vancomycin. In majority of the 
cases, (70%) empiric antibiotic combinations were stopped in 72 h. Conclusion: This is 
the first report of antibiotics use in PICU from our country, which shows that antibiotics 
are prescribed universally in our PICU. Strategies to assess the need for antibiotic use 
are needed.
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use of antibiotics has resulted in emergence of antibiotic 
resistance which is an important clinical, economic, 
and public health problem.[6] Several papers have been 
published regarding the use of antibiotics both in adult 
and pediatric critically ill patients from developed 
countries.[1,2,6,7] They showed that they were able to 
identify reasons for not using antibiotics in many patients. 
This kind of surveillance leads to antibiotic stewardship 
program and proper use. However, availability of such 
data is limited from PICU of developing country specially 
ours. The objective of this study is to evaluate the use 
of antibiotic in relation to diagnosis and bacteriological 
findings in the PICU of a tertiary hospital. This would 
help in instituting strategies to prevent inappropriate use 
hence improving the outcome and reduce cost.
Methods
We reviewed medical records of all children 
(age -1 month–16 years) admitted in our closed 
multidisciplinary-cardiothoracic PICU from January to 
June 2013 after Ethical Review Committee approval. Data 
collected included demographic variables (age, gender), 
clinical, laboratory, microbiological data, and use of 
antibiotics on a structured data collection sheet. For each 
patient the cumulative number of antibiotics prescribed 
during the length of stay in PICU was recorded. All 
diagnosis of infections was recorded according to the 
diagnostic criteria of IPSCC 2005. The indications of 
antibiotics were categorized as prophylaxis, empirical, 
and therapeutics. Prophylactic antibiotic treatment was 
defined as administration of antibiotics without any 
evidence of infection to prevent infection in patients 
at risk of developing infection mainly in postoperative 
patients. Empiric antibiotic treatment was labeled to be 
present when antibiotics were prescribed for systemic 
signs of infection without identifying a specific source of 
infection. Therapeutic antibiotic treatment was defined 
as treatment based on culture and sensitivity report. 
For each antimicrobial, the indication and duration 
of antibiotics were recorded. The indication for use of 
each antibiotic prescribed during the PICU stay was 
documented using above criteria. Descriptive statistics 
were applied using SPSS (Statistical Package for Social 
Sciences) version 19. Data are present as frequency with 
percentage and median with inter quartile range (IQR).
Results
During the study period, 240 patients were admitted 
to PICU. Baseline characteristics of enrolled patients are 
described in Table 1. The median age of our sample was 
26 months with IQR of 93 and 150 (62.5%) were male. The 
most common diagnostic categories were postoperative 
congenital heart diseases (35%), acute neurological disorders 
including central nervous system infections (26.6%) 
followed by respiratory problems (14.6%) [Table 2].
Antibiotics surveillance data
All patients (100%) admitted to our ICU received 
antibiotics. Prophylactic therapy (three doses as per our 
hospital policy) was used in 103/240 cases (43%) prior 
to surgical procedures. Empirical therapy was used in 
42% (101/240)  while 15% (36/240) received antibiotics 
therapeutically.
The median number of antibiotics received per 
patient in our PICU was 3 with a range of 1–7 (IQR 2), 
25% (n = 60) received one antibiotic, 23% (n = 56) received 
two antibiotics, 29% (n = 70) received three antibiotics, 
rest received ≥4 antibiotics in our cohort [Figure 1]. 
>1 antibiotic either as a combination or sequential 
therapy was prescribed in 76% of the patients.
The most commonly used drugs were cefazolin, 
meropenem, vancomycin, and ceftriaxone, [Figure 2]. 
The most frequently used combinations included 
meropenem and vancomycin (24%, n = 58/240) and 
meropenem, vancomycin, and colistin (12%; 28/240). 
Of those who received empiric therapy, 33% of patients 
received combination antibiotics. Combination therapy 
with meropenem and vancomycin as prophylaxis after 
surgical repair or replacement of cardiac valves was 
Table 1: Basic characteristics of patients admitted in PICU 
who received Antibiotics
Variable No Percent
Age in mo (median with IQR) 26 (93) ‑
Duration of antibiotics
Mean±SD
10.15±7.43 ‑
Gender (male) 150 62.5
Source of admission
ER 80 33.33
Ward 60 25.7
OR 100 41
Outcome (expired) 22 16.9
Blood culture positive 76 32
PICU: Pediatric Intensive Care Unit; IQR: Inter quartile range; SD: Standard deviation
Table 2: Diagnostic categories of patients who received 
antibiotics in PICU
Diagnosis Number (percentage)
Medical 136 (57)
Respiratory 48 (20)
Neurological 44 (18.5)
Cardiac/shock 22 (9)
Miscellaneous 22 (9)
Surgery/trauma 104 (43)
Total 240 (100)
PICU: Pediatric Intensive Care Unit
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prescribed to three patients. The median duration of 
antibiotic use was 4 days with IQR of 2 days, and median 
PICU length of stay was 4 days with IQR of 3 days. The 
median duration of antibiotics use for prophylactic 
therapy was 1 day with IQR of 2. The median duration 
of empirical therapy was 1 day with IQR of 4 days. 
The empirical therapy was deescalated after 72 h in 
70% (n = 72). Failure to discontinue accounted for 
15% of all cases in whom culture report was negative; 
prolonged empiric treatment was continued (5–7 days) 
as therapeutic in 15% (n = 15) as the culture sensitivity 
report showed that organism is sensitive to the drug 
prescribed empirically. Therapeutic use of antibiotics 
was 15%.
A total of 280 blood cultures, 50 tracheal aspirates 
sample, and 32 urine samples were sent for analysis 
during study period and 55 micro-organisms were 
isolated from 362 specimens of 140 patients who had 
one or more specimens cultured during study period. 
The blood cultures were positive in 14%, and tracheal 
aspirates were positive in 24%.  Most common isolates 
in blood were Acinetobacter, Staphylococcus and Klebsiella 
pneumonia (KP). Tracheal cultures most commonly 
yielded Acinetobacter and KP. Rate of MDR was 7% in our 
cohort, and the most common isolates were Acinetobacter 
and KP. Overall, 22/240 (9%) patients died during the 
study period.
Discussion
Good antibiotics prescribing practice means using 
most effective, least toxic, and least costly antibiotic for 
a precise duration.[8] Our study highlights some very 
important points. The entire patient population (100%) 
received antibiotics as prophylaxis or empirical therapy 
mostly without always having evidence of any infection 
as compared to other studies that reported antibiotic 
usage of 50–94% in their PICUs.[1,2,9] In our study, 76% 
patients received combination or multiple antibiotics 
therapy (2 or more drugs). These findings are concerning 
since our MDRO rate, and mortality is high and all of our 
patients receive antibiotics whether indicated or not. Our 
study shows that empirical therapy was prescribed to the 
majority (42%) of the patients without any microbiologic 
evidence of infection. This might have been due to the 
reason of limited microbiologic yield and the critical 
condition of the patients admitted to PICU. A similar 
study of antibiotic use in PICU of Canada showed 
27–40% usage of empiric antibiotic treatment[2] while 
another study by Ding et al. from China showed that 
71% of their patients in PICU received empiric antibiotic 
treatment.[1] Failure to stop empirical therapy was found 
in 15% of the patients with no micro-organisms isolated 
which is similar to a study in Canada.[2]
In our study, 76% patients received more than two 
antibiotics simultaneously which is much higher than 
reported by Ding et al., Blinova et al. and Grohskopf et al.
[1,2,10] They reported use of two or more antibiotics in 47%, 
55–69%, and 40% of their patients, respectively. These 
variations can be due to difference in prescribing practices, 
differences in rates and types of infections and antibiotic 
guidelines among countries but such a high rate of 
combination therapy cannot be justified except in certain 
conditions, like in very critical patients, with the purpose 
of providing broad coverage against micro-organisms or 
when more than one organism is isolated.
Prophylaxis was given in 43% of patients for 
1 day  which was prescribed for the postoperative 
patient, the  majority (35%) of whom were postoperative 
congenital heart diseases. Most common prophylactic 
antibiotic prescribed was cephazolin which is the 
standard prophylactic antibiotic being used in these 
patient.
Another alarming finding is increased use of 
carbapenems (meropenem) which was found to be the 
Figure 2: Most commonly used antibiotics and their indicationFigure 1: No of antibiotics per patient
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most commonly used drug after cephazolin, mostly 
in combination with vancomycin. In contrast, other 
studies by Ding et al. and Blinova et al. report use of 
meropenem to be 2.5–12.5% respectively.[2,6] Other 
commonly used drugs were ceftriaxone and cephazolin, 
similar to other studies.[2,7] However, our use of broad 
spectrum combination therapy for suspected nosocomial 
infections was very high as compared to other studies.[1,2] 
Several different strategies can be developed to reduce 
the antibiotic use including hospital formulary 
restriction, practitioners’ education and feedback 
activities and teaming up with an infectious disease 
specialist, microbiologist, and clinical pharmacist.[10]
Our study has the limitation of being a retrospective 
review, single center study, and PRISM score was not 
calculated. None the less this adds much value to the 
scarce data available on antibiotic use in our country 
especially in a dedicated PICU which can be used to 
guide proper antibiotic use by different interventions 
mentioned above.
Conclusion
This study provides valuable insight to antibiotics 
usage in PICU of a developing country. Our data points 
that overuse of antibiotics exists in our PICU. It is 
recommended to guide antibiotics utilization according 
to microbiology and discontinue empirical therapy as 
soon as possible. Continued surveillance and large, 
multicenter studies are recommended.
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